Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7339370

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of group
Business results of group
Net sales
JPY
63,038,000 JPY
35,000,000 JPY
Ordinary profit (loss)
-363,292,000 JPY
-1,913,816,000 JPY
-323,092,000 JPY
Net assets
1,748,158,000 JPY
1,474,097,000 JPY
1,835,577,000 JPY
Total assets
2,143,742,000 JPY
2,040,598,000 JPY
2,280,737,000 JPY
Basic earnings (loss) per share
-18.24
-108.92
-18.69
Diluted earnings per share
Equity-to-asset ratio
0.812 xbrli:pure
0.715 xbrli:pure
0.801 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.